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Articles
Virtual-reality-based cognitive behavioural therapy versus 
waiting list control for paranoid ideation and social avoidance 
in patients with psychotic disorders: a single-blind 
randomised controlled trial
Roos M C A Pot-Kolder*, Chris N W Geraets*, Wim Veling, Marije van Beilen, Anton B P Staring, Harm J Gijsman, Philippe A E G Delespaul, 
Mark van der Gaag
Summary
Background Many patients with psychotic disorders have persistent paranoid ideation and avoid social situations 
because of suspiciousness and anxiety. We investigated the effects of virtual-reality-based cognitive behavioural 
therapy (VR-CBT) on paranoid thoughts and social participation.
Methods In this randomised controlled trial at seven Dutch mental health centres, outpatients aged 18–65 years with 
a DSM-IV-diagnosed psychotic disorder and paranoid ideation in the past month were randomly assigned (1:1) via 
block randomisation to VR-CBT (in addition to treatment as usual) or the waiting list control group (treatment as 
usual). VR-CBT consisted of 16 individual therapy sessions (each 1 h long). Assessments were done at baseline, after 
treatment (ie, 3 months from baseline), and at a 6 month follow-up visit. The primary outcome was social participation, 
which we operationalised as the amount of time spent with other people, momentary paranoia, perceived social 
threat, and momentary anxiety. Analysis was by intention to treat. This trial was retrospectively registered with 
ISRCTN, number 12929657.
Findings Between April 1, 2014, and Dec 31, 2015, 116 patients with a psychotic disorder were randomly assigned, 
58 to the VR-CBT group and 58 to the waiting list control group. Compared with the control, VR-CBT did not 
significantly increase the amount of time spent with other people at the post-treatment assessment. Momentary 
paranoid ideation (b=–0·331 [95% CI –0·432 to –0·230], p<0·0001; effect size –1·49) and momentary anxiety (–0·288 
[–0·438 to –0·1394]; p=0·0002; –0·75) were significantly reduced in the VR-CBT group compared with the control 
group at the post-treatment assessment, and these improvements were maintained at the follow-up assessment. 
Safety behaviour and social cognition problems were mediators of change in paranoid ideation. No adverse events 
were reported relating to the therapy or assessments.
Interpretation Our results suggest that the addition of VR-CBT to standard treatment can reduce paranoid ideation 
and momentary anxiety in patients with a psychotic disorder.
Funding Fonds NutsOhra, Stichting tot Steun VCVGZ.
Introduction
People with psychotic disorders often avoid public and 
social activities. Their social networks are generally small 
and they spend more time alone than people without a 
psychotic disorder.1 Many people with psychotic disorders 
do not have romantic partners, and the unemployment 
rate is high.2,3 As many as 90% of patients have paranoid 
ideation to some degree.4 Often, such ideation is strong 
and manifests as paranoid delusions, which are 
characterised by unfounded anticipation of intentional 
harm inflicted by other people. The anxiety resulting 
from paranoid ideation strongly contributes to social 
avoidance. This conditioned avoidance is not always 
affected by use of antipsychotic medication.4 Cognitive 
behavioural therapy (CBT) is the most effective 
psychological treatment for people with psychotic 
disorders.5 The effect sizes of CBT on paranoid delusions 
and social functioning are small to medium, but can be 
improved by more emphasis on behavioural rather than 
cognitive change, and by more person-specific 
exposure5—a key element of CBT.
Exposure-based therapeutic exercises for paranoid 
ideation have several limitations. First, the social 
environment and reactions of others cannot be controlled 
by the therapist—relevant events might not occur, or 
unwanted events can suddenly occur. Second, exposure 
takes place between therapy sessions, and thus therapist 
feedback is retrospective and based on patient reports, 
which could be inaccurate because of biases.6 Finally, 
many patients are reluctant or unable to undergo 
exposure because of strong paranoid fears or negative 
symptoms.
These limitations could be overcome through virtual 
reality. The virtual social world is a controlled environment 
and exercises are done with the guidance of a therapist. 
Virtual reality is effective and safe for treating anxiety.7 
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It is safe to use in people with psychotic disorders,8 and 
studies suggest promising results for several virtual 
reality interventions, including for social skills training, 
auditory hallucinations, and paranoid ideation.9,10 These 
findings suggest that virtual-reality-based CBT (VR-CBT) 
could be an effective, affordable, acceptable, and 
accessible form of treatment for patients with paranoid 
ideation and social withdrawal.
We did a randomised controlled trial to establish the 
effectiveness of VR-CBT, compared with treatment as 
usual, in improving the quantity and quality of social 
participation in patients with psychotic disorders who 
experience paranoid ideation and social avoidance. The 
primary hypothesis was that VR-CBT would lead to 
more time spent with other people, and a decrease in 
momentary paranoia, perceived social threat, and 
anxiety during real-life social activities. Our secondary 
hypotheses were that safety behaviours and paranoid 
ideation would be reduced by VR-CBT, that levels of 
social anxiety, depression, stigma, cognitive biases, and 
cognitive limitations would decline, and that social 
functioning, quality of life, and schematic beliefs would 
improve. Furthermore, we hypothesised that changes 
in safety behaviour and cognition (biases and mental 
schemas) would mediate the reduction in paranoia. 
Cost-effectiveness analyses will be reported in a 
separate paper.
Methods
Study design and participants
We did a single-blind randomised controlled trial of 
VR-CBT plus treatment as usual versus treatment as 
usual only in outpatients at seven Dutch mental health 
centres. Details of the study protocol have been 
published.11 Inclusion criteria were a DSM-IV diagnosis 
of a psychotic disorder based on the Mini-International 
Neuropsychiatric Interview,12 the Schedules for Clinical 
Assessment in Neuropsychiatry,13 or the Comprehensive 
Assessment of Symptoms and History14 (varied by 
centre); avoidance of either shops, streets, public 
transport, or bars or restaurants; paranoid ideation in 
the past month (defined as a score greater than 
40 on the Green et al Paranoid Thoughts Scale15); and 
age 18–65 years. Exclusion criteria were an IQ of 70 or 
lower (established by a valid instrument such as the 
Wechsler Adult Intelligence Scale or the Wechsler 
Intelligence Scale for Children); insufficient mastery of 
the Dutch language; and history of epilepsy. The 
protocol was approved by the medical ethical committee 
of VU University Medical Center Amsterdam (METC 
number NL37356.058.12). Patients were informed 
about the study by their treating psychiatrist, 
psychologist, or psychiatric nurse. If a patient was 
eligible and willing to participate, written informed 
consent was obtained.
Randomisation and masking
After a baseline assessment, patients were randomly 
assigned. Research assistants blinded to treatment 
allocation did the post-treatment and follow-up 
assessments. Assessors were instructed to stop the 
assessment in case of unblinding, and the assessment 
was repeated by another research assistant. (An assessor 
had to be replaced on three occasions.) Block random-
isation was used to allocate patients (1:1) to the VR-CBT 
or control group. Each block had six assignments 
Research in context
Evidence before this study
Paranoid ideation is common in patients with psychotic 
disorders. The anxiety resulting from paranoid ideation 
strongly contributes to social avoidance. Cognitive behavioural 
therapy is the most effective psychological treatment for this 
symptom, but effects sizes are small to medium at best. The 
positive results of using virtual reality to treat anxiety disorders 
suggest that virtual reality might be used to improve treatment 
for anxiety and avoidance of social situations resulting from 
paranoid ideation. We searched MEDLINE with the terms 
(Virtual Reality) AND (Delus* OR Paranoi* OR Psychosis OR 
Psychotic OR Schizophren*) for articles published in any 
language before Sept 14, 2017. We identified 94 peer-reviewed 
papers. Research showed exposure of patients with a psychotic 
disorder to immersive virtual environments is safe and that 
virtual reality can be used to elicit paranoid ideation and 
anxiety in patients with a psychotic disorder, which suggests 
that the creation of virtual environments for treatment is 
feasible. Only one of the identified papers was a randomised 
controlled trial of virtual reality therapy for reducing paranoid 
ideation. This small (n=30) experimental study showed large 
reductions in delusional conviction and real-world distress.
Added value of this study
We did the first randomised controlled trial (to our knowledge) 
of virtual-reality-based cognitive behavioural therapy with the 
aim of improving social functioning and reducing paranoid 
ideation in patients with psychotic disorders. We found that the 
addition of virtual reality cognitive behavioural therapy to 
standard therapy reduced paranoid ideation, anxiety, and use of 
safety behaviours in social situations compared with standard 
therapy alone. Results of the mediation analysis supported the 
importance of reducing safety behaviours and modifying social 
cognition in the treatment of paranoid delusions.
Implications of all the available evidence
Virtual-reality-based cognitive behavioural therapy  is safe and 
effective in patients with psychotic disorders. Future research 
should compare virtual-reality-based cognitive behavioural 
therapy with standard cognitive behavioural therapy in terms 
of treatment effects and cost-effectiveness. 
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per condition. If a centre had more patients, a second 
randomised block was allocated. Blocks were made 
with the scientific randomisation program Research 
Randomizer by the independent randomisation bureau 
of Parnassia, which also allocated patients to groups.
Procedures
The two groups were compared at baseline, after 
treatment (3 months after baseline), and at follow-up 
(6 months after baseline). Participants who dropped out 
of treatment were asked to complete the post-treatment 
and follow-up assessments. Instructions were given to 
psychiatrists not to change patients’ medication during 
the study. When patients reported medication changes, 
these changes were checked with their clinician. No 
additional psychological treatments for paranoid ideation 
or social participation were allowed. Participants in the 
control group were offered VR-CBT after follow-up.
Four virtual social environments (a street, bus, café, and 
supermarket) were created with Vizard software 
(appendix). Within the environment, participants could 
move by operating a Logitech F310 Gamepad. They used a 
Sony HMZ-T1/T2/T3 Head Mounted Display with a high-
definition resolution of 1280 × 720 per eye, with 
51·6 diagonal field of view, and a 3DOF tracker for head 
rotation. Therapists could vary the number of human 
avatars (0–40), the characteristics of the avatars (including 
sex and ethnicity), and the avatars’ responses to the patient 
(neutral or hostile, eye contact) to match the paranoid 
fears of the patient. Therapists could also make the avatars 
say pre-recorded sentences. Because these stimuli 
were directly controlled by the therapist, personalised 
treatment exercises were created for each patient.
VR-CBT consisted of 16 sessions over 8–12 weeks. 
Sessions lasted 1 h, 40 min of which comprised virtual-
reality exercises. The remaining 20 min were used to plan 
and reflect on exercises. An individualised case 
formulation guided exposure to idiosyncratic social 
environmental cues that elicited fear, paranoid thoughts, 
and safety behaviours. Patients and therapists 
communicated during virtual-reality sessions to explore 
and challenge suspicious thoughts during social 
situations, drop safety behaviours during social situations 
(such as avoiding eye contact with, keeping distance 
from, and refraining from communication with avatars), 
and test harm expectancies. No homework exercises were 
given between sessions to test the effects of the in-virtuo 
exposure without the effects of structured in-vivo 
exposure. VR-CBT therapists were psychologists with at 
least basic CBT training. They received 2 days’ training in 
VR-CBT. The VR-CBT manual described a structured 
treatment plan for all 16 sessions. Therapists were 
supervised in a group for 4 h every month. All therapy 
sessions were recorded on audiotapes. Experienced CBT 
psychologists anonymously rated a random selection of 
sessions (two per therapist) for treatment fidelity with the 
Cognitive Therapy Rating Scale.16
Patients in the waiting list control group received 
treatment as usual—antipsychotic medication, regular 
contact with a psychiatrist to control symptoms, and 
regular contact with a psychiatric nurse to improve 
self-care, daytime activities, and social and community 
functioning.
Outcomes
The primary outcome was social participation—a 
multidimensional construct with a behavioural, objective 
dimension and a subjective, experiential dimension. We 
operationalised objective social participation as the 
amount of time spent with others and subjective social 
participation as momentary paranoia, perceived social 
threat, and momentary anxiety in company.
The experience sampling method (ESM)—a structured 
diary method in which individuavls are asked in daily 
life to report their momentary thoughts, feelings, 
symptoms, social contexts, and appraisal of social 
contexts—was used to assess momentary outcomes. 
ESM has been used by patients with psychotic disorder, 
with or without symptoms.17 The method used in this 
study, PsyMate, has high ecological validity.18 All 
participants carried a PsyMate electronic device for 
assessments, which beeped at quasi-random moments 
ten times a day during 6 days. At each beep, the device 
collected self-assessments on a seven-point Likert scale, 
ranging from 1 (“not at all”) to 7 (“very”). Reports had to 
be completed within 15 min of the beep. To be included 
in the analysis, participants had to complete diary 
entries for at least one-third of the beeps (ie, a minimum 
of 20 measurements).
For ESM, items from previous studies were used. 
Principal component analyses have been done previously 
for ESM affect items, and identified the following factors: 
negative affect, positive affect, momentary paranoia,19 
and perceived social threat.17 A principal component 
analysis with oblique rotation and Kaiser normalisation 
for the person-centred data from our study identified 
these four factors according to the Kaiser criterion 
(eigenvalue >1). We used the momentary paranoia and 
perceived social threat subscales. The principal com-
ponent analysis confirmed the perceived social threat 
factor for all four items (factor loadings ranging from 
0·57 to 0·80) and partly confirmed momentary paranoia 
for three items (factor loadings ranging from 
0·52 to 0·83). The three-item momentary paranoia 
subscale was used.
Time spent with others was measured by the proportion 
of beeps that participants reported to be in company of 
other people (not mental health professionals). 
Momentary paranoia was calculated as the mean score of 
the three items: “I feel that others might hurt me”, “I feel 
that others dislike me”, and “I feel suspicious”. Perceived 
social threat was calculated as the mean score on the 
items “I like this company [reversed score]”, “In this 
company, I feel accepted [reversed score]”, “I would 
For more on Research 
Randomizer see https://www.
randomizer.org
For more on PsyMate see  
www.psymate.eu
See Online for appendix
For more on virtual reality 
treatments for mental health 
see www.vrmentalhealth.nl/en
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rather be alone”, and “In this company, I feel threatened”. 
Scores on the item “I feel anxious” when in the presence 
of other people were used to establish momentary 
anxiety.
Secondary outcomes for symptom measures were the 
Safety Behaviour Questionnaire-Persecutory Delusions,20 
the Green et al Paranoid Thoughts Scale,15 the Social 
Interaction Anxiety Scale,21 and the Beck Depression 
Inventory.22 Functional outcomes were rated with the 
Social and Occupational Functioning Assessment Scale23 
and the Manchester Short Assessment of Quality of Life.24 
Stigma was assessed with the Internalized Stigma of 
Mental Illness questionnaire.25 To examine putative 
working mechanisms of the therapy, cognitive constructs 
were assessed with the Brief Core Schema Scales26 and the 
self-reported Davos Assessment of Cognitive Biases Scale.27 
Medication adherence was measured with the Brief 
Adherence Rating Scale.28 After the fourth and eighth 
sessions, presence in virtual reality was assessed with the 
Igroup Presence Questionnaire,29 and cybersickness 
symptoms with the Simulator Sickness Questionnaire.30
Statistical analyses
Because, to our knowledge, VR-CBT has never been tested 
before and ESM had not previously been used as a primary 
outcome in intervention studies, we conservatively 
estimated sample size by assuming a moderate effect size 
of 0·5 with a power of 0·8, an α of 0·05 and a two-sided 
independent t test. The estimated sample size was 64 for 
each group. We postulated an attrition rate of 20%, 
and thus set 160 as the total sample size.
For primary outcomes, we applied the Bonferroni 
correction for four tests, with a significance level 
of 0·0125. For all other outcomes, the significance level 
was 0·05. Group characteristics were compared at 
baseline with t tests, non-parametric Mann-Whitney 
U tests, or χ² tests.
All data had a hierarchical structure, with repeated 
measurements (level 1) nested within individuals 
(level 2). Multilevel analyses were done to take into 
account that intra-individual observations are more 
similar than inter-individual observations. Logistic multi-
level regression analyses were done for objective social 
participation; multilevel regression analyses were done 
for all other outcomes. All models included a random 
intercept for participant. We used the maximum-
likelihood method and the covariance structure identity 
for estimation. All data were analysed by intention to 
treat. The treatment effect was established with the group 
by time interaction for the post-treatment and follow-up 
assessments separately. Post-treatment and follow-up 
data were each compared to baseline. In all analyses age, 
sex, ethnicity, and education were included as covariates. 
If baseline differences between groups were noted, this 
variable was included as a covariate in all analyses. We 
calculated effect sizes for group by time interaction 
effects with the z test statistics to determine r.31 To 
facilitate interpretation, we transformed r into Cohen’s 
dpp (the superscript shows that the effect size was based 
on pre–post measures).32
Two parallel multiple mediation analyses were done to 
examine the mediating effects of VR-CBT on paranoid 
ideation at the post-treatment assessment. The analyses 
had different outcome measures—paranoid ideation 
(Green et al Paranoid Thoughts Scale total score) and 
momentary paranoia (ESM; appendix). Selection of 
potential mediators was based on the results of our 
multilevel analysis. We used a significance level of 
0·10 for the post-treatment treatment effect variables as 
the cutoff for inclusion in the mediation analysis. 
Analyses were done with the PROCESS macro,33 which 
uses linear regression to estimate indirect effects 
according to the methods recommended by Hayes and 
Rockwood for clinical studies.34 This method is based on 
a modern framework, and, by contrast with the causal 
steps approach, in which a series of criteria are required 
858 people assessed for eligibility
742 excluded
 486 did not meet inclusion criteria
 51 did not respond to phone or postal contact
 1 died of unrelated causes
 204 declined to participate
 94 for unknown reasons 
 59 had no need or wish for treatment
 22 had no time for treatment
 16 unable or unwilling to travel to location
                   13 had other reasons
8 did not attend post-treatment 
 assessment
 6 declined to participate further
 2 did not receive intervention 
  because of clerical errors
116 randomly assigned
58 allocated to virtual-reality-based cognitive 
 behavioural therapy group
58 allocated to waiting list control group
5 did not attend post-treatment 
 assessment
12 lost to follow-up
     9 declined to participate further
     2 were lost because of clerical errors
      1 died from unrelated causes
50 attended post-treatment assessment 53 attended post-treatment assessment
46 attended 6 month follow-up 53 attended 6 month follow-up 
58 included in intention-to-treat group 58 included in intention-to-treat group
5 lost to follow-up
    5 declined to participate further 
Figure: Trial profile
For more on PROCESS macro see 
processmacro.org
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to establish mediation,35 it focuses solely on quantification 
of indirect effects. Hayes and Rockwood also emphasise 
the value of mediation analysis for research if only 
two measurement moments are used. Post-treatment 
scores were added as mediators, and baseline scores for 
the outcome variables and mediators were added to 
the models as covariates. Least-square path analysis 
was used and the bootstrap confidence interval 
(5000 permutations) was applied to estimate indirect 
effects. We used Stata (version 13.1) and SPSS 
(version 24.0.0.0) for all analyses. Because of an oversight, 
prospective trial registration was overlooked, but the trial 
was registered retrospectively with ISRCTN, number 
12929657. Details of our initial ethics approval and 
protocol are in the appendix.
Role of the funding source
The study funders had no role in the study design; data 
collection, analysis, or interpretation; or writing of the 
Article. RMCAP-K, CNWG, WV, PAEGD, and MvdG had 
full access to all study data, and RMCAP-K, the 
corresponding author, had final responsibility for the 
decision to submit for publication.
Results
Between April 1, 2014, and Dec 31, 2015, 116 patients with 
a psychotic disorder were randomly assigned (figure). 
Patients who were included in the study did not differ 
significantly in terms of frequency and severity of 
paranoid ideation from those who chose not to participate 
(we did separate analyses for patients who were eligible 
but did not consent to be contacted about study 
participation, those who had no wish, need, or time for 
treatment, those who were unable to travel to the 
treatment location, and those who gave permission for 
contact but did not respond; data not shown).
Sociodemographic characteristics were well balanced 
between groups (table 1). Participants who dropped out 
from VR-CBT did not differ from participants who 
completed VR-CBT in baseline paranoid ideation or 
safety behaviours (data not shown). We noted no 
differences in baseline paranoid ideation or safety 
behaviour between participants who refrained from 
follow-up measurements and those who completed all 
measurements (data not shown). Cybersickness was 
recorded (appendix), but only one participant dropped 
out because of nausea, rendering further statistical 
investigation irrelevant. No adverse events relating to 
either VR-CBT or the assessments were reported.
11 patients (19%) in the VR-CBT group dropped out of 
therapy (including four who never started treatment). 
Seven patients discontinued treatment: one was too afraid 
(completed one session), one had no time (one session), 
one was not willing to travel to therapy location 
(two sessions), one had nausea (two sessions), one was 
unable to attend sessions sober (three sessions), and two 
found the head-mounted display too uncomfortable to 
tolerate (five and six sessions, respectively). Participants 
felt sufficiently present in the virtual environments on all 
three subscales of the Igroup Presence Questionnaire 
(range 0–6): spatial presence (mean 3·79), involvement 
(mean 3·16), and realness (mean 2·96). 28 sessions were 
rated for treatment fidelity. Therapists had “good” to 
“very good” adherence to the protocol and CBT quality 
(mean 4·5 [range 2·4–5·9]).
The VR-CBT group reported 17 changes of anti-
psychotics: ten doses were lowered, three doses were 
raised, and four patients changed medication. 18 changes 
were reported in the control group: 11 doses were 
lowered, six doses were raised, and one person changed 
medication. No significant differences were noted 
between patients who had any medication changes and 
those who had no changes at baseline, at 3 months after 
treatment, or at follow-up (data not shown).
At baseline, no significant differences were noted 
between the VR-CBT and control groups, except in use of 
safety behaviours (table 2), which was significantly lower 
in the control group (24·1) than in the VR-CBT 
group (28·8; z=–2·09; p=0·036). Baseline level of safety 
behaviours was thus included as a covariate in analyses. 
All participants completed ESM measurements at 
baseline (mean number of completed self-assessments 







Age, years 36·5 (10) 39·5 (10)
Non-Dutch origin 15 (26%) 25 (43%)
Sex
Male 40 (69%) 42 (72%)
Female 18 (31%) 16 (28%)
Education
None or primary 16 (28%) 16 (28%)
Vocational 18 (31%) 24 (41%)
Secondary 9 (16%) 9 (16%)
Higher 15 (26%) 9 (16%)
DSM-IV diagnosis
Schizophrenia 46 (79%) 49 (85%)
Schizoaffective disorder 1 (2%) 5 (9%)
Delusional disorder 1 (2%) 0 (0%)
Not-otherwise specified 
psychotic disorder
10 (17%) 4 (7%)
Duration of illness, years 13·3 (10·6) 14·9 (9·5)
Medication use
Antipsychotics 54 (93%) 57 (98%)
Olanzapine equivalent of 
prescribed antipsychotic 
medication (mg per day)
10·5 (6·8) 11·0 (8·3)
Antidepressants 15 (26%) 17 (29%)
Data are n (%) or mean (SD).
Table 1: Baseline characteristics
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post-treatment assessment sufficiently (43·1 [10·1]), and 
87 participants completed the follow-up (43·2 [11·1]).
For amount of time spent with others, the treatment 
effect at the post-treatment visit compared with baseline 
was not significant (dpp 0·25; p=0·178), but the treatment 
effect at follow-up compared with baseline was (dpp 0·50; 
p=0·0090; table 3). Time spent with others decreased by 
2·4% in the control group between baseline and the follow-
up assessment, whereas the amount of time marginally 
increased by 0·3% in the VR-CBT group.
Between baseline and the post-treatment assessment, 
a large reduction was noted in momentary paranoia 
(–0·350) in the VR-CBT group, whereas a slight increase 
was noted in the control group (0·162; dpp –1·49; 
p<0·0001; table 3). A significantly larger decrease in 
momentary anxiety was noted in the VR-CBT group than 
in the control (dpp 0·75; p=0·0002; table 3). The effect 
sizes for momentary paranoia and anxiety remained 
significant at follow-up. When the mean of the original 
four-item subscale was used (instead of the three-item 
subscale), the pattern of results for momentary paranoia 
was identical (data not shown). No significant interaction 
effects were noted for perceived social threat at the post-
treatment (d pp –0·33) or follow-up (d pp 0·36) assessments 
(table 3).
Compared with the control group, use of safety 
behaviours decreased significantly in the VR-CBT group 
at both the post-treatment and follow-up assessment 
(table 3). The largest reduction at the post-treatment visit 
was for the in-situ safety behaviours subscale (binteraction –3·7 
[95% CI –6·2 to –1·2]; z –2·93, p=0·0033).
Treatment effects on paranoid ideation were significant: 
at the post-treatment and follow-up assessments, levels 
of ideas of persecution and social reference were lower in 
the VR-CBT group than in the control group (table 3). 
Depression and anxiety were not significantly lower in 
the intervention than in the control group (table 3). The 
VR-CBT group had improvements in self-stigmatisation 
and social functioning at follow-up whereas the control 
group did not (table 3). Quality of life at the post-treatment 
or follow-up assessments did not differ significantly 
between groups (table 3).
Measurement instrument Virtual-reality-based cognitive behavioural therapy group Waiting list control group
Baseline After treatment Follow-up Baseline After treatment Follow-up
Primary outcomes
Time spent with others Experience Sampling Method 0·416 (0·26) 0·404 (0·24) 0·419 (0·24) 0·364 (0·27) 0·323 (0·28) 0·340 (0·30)
Momentary paranoia Experience Sampling Method 3·064 (1·39) 2·714 (1·38) 2·719 (1·37) 3·140 (1·43) 3·302 (1·60) 3·354 (1·56)
Perceived social threat Experience Sampling Method 2·703 (0·86) 2·805 (1·01) 2·728 (1·04) 2·816 (0·91) 2·837 (0·98) 2·752 (0·99)
Momentary anxiety Experience Sampling Method 2·986 (1·12) 2·586 (1·14) 2·645 (1·21) 3·259 (1·50) 3·221 (1·56) 3·218 (1·49)
Secondary outcomes
Ideas of persecution Green et al Paranoid Thoughts Scale 41·2 (18·9) 33·4 (17·1) 31·4 (17·9) 36·2 (16·3) 38·2 (17·9) 38·4 (18·7)
Ideas of social reference Green et al Paranoid Thoughts Scale 43·6 (15·9) 35·4 (15·5) 34·0 (16·1) 40·4 (15·7) 38·7 (14·9) 39·1 (15·4)
Safety behaviours Safety Behaviour Questionnaire—
Persecutory Delusions
28·8 (14·2) 21·1(16·0) 20·2 (16·2) 24·1 (15·0) 23·8 (16·5) 22·5 (13·5)
Social interaction anxiety Social Interaction Anxiety Scale 43·8 (13·1) 36·8 (13·1) 36·2 (13·0) 43·1 (14·9) 39·2 (15·7) 40·3 (15·1)
Depression inventory Beck Depression Inventory 17·2 (9·5) 16·0 (10·4) 13·3 (10·1) 17·6 (9·7) 15·0 (10·0) 15·8 (9·9)
Quality of life Manchester Short Assessment of 
Quality of Life
4·3 (0·9) 4·3 (1·0) 4·4 (1·0) 4·2 (0·9) 4·3 (0·8) 4·3 (0·8)
Social functioning Social and Occupational 
Functioning Assessment Scale
49·6 (8·0) 50·1 (8·7) 51·4 (10·7) 49·6 (8·3) 49·5 (8·6) 47·6 (8·6)
Stigma Internalized Stigma of Mental Illness 2·4 (0·3) 2·3 (0·4) 2·2 (0·4) 2·4 (0·4) 2·4 (0·5) 2·4 (0·4)
Jumping to conclusions DACOBS 26·8 (5·4) 25·4 (5·6) 25·4 (5·3) 25·0 (5·1) 25·2 (5·3) 24·8 (5·9)
Belief inflexibility DACOBS 22·6 (5·6) 23·1 (6·6) 22·2 (6·2) 22·0 (5·2) 22·0 (5·3) 21·5 (4·7)
Attention for threat DACOBS 29·6 (6·1) 27·7 (7·2) 27·6 (7·2) 28·0 (6·4) 28·5 (6·2) 27·9 (6·1)
External attribution DACOBS 24·8 (6·8) 24·3 (6·7) 22·8 (6·3) 24·3 (7·0) 23·8 (6·4) 24·1 (6·7)
Social cognitive problems DACOBS 29·7 (6·1) 27·4 (7·1) 26·6 (6·8) 27·5 (6·0) 27·5 (6·2) 27·6 (6·3)
Subjective cognitive problems DACOBS 26·1 (5·5) 25·9 (6·3) 25·2 (6·4) 26·2 (6·7) 26·5 (6·1) 25·0 (5·6)
Safety behaviour DACOBS 22·8 (6·5) 20·5 (6·5) 20·3 (7·1) 20·2 (7·4) 20·0 (7·8) 20·4 (7·1)
Negative self-core schema Brief Core Schema Scales 5·8 (4·7) 4·8 (4·6) 4·6 (4·5) 5·6 (4·5) 4·8 (4·3) 5·1 (4·0)
Negative others core schema Brief Core Schema Scales 6·6 (7·2) 5·1 (6·5) 5·0 (6·5) 5·6 (6·2) 5·3 (5·9) 5·8 (6·5)
Positive self-core schema Brief Core Schema Scales 8·3 (5·3) 8·4 (6·1) 8·9 (6·0) 7·0 (4·2) 8·1 (5·1) 7·1 (4·5)
Positive others core schema Brief Core Schema Scales 7·9 (5·3) 8·1 (6·1) 9·3 (6·5) 6·2 (5·2) 6·9 (5·9) 6·5 (4·6)
Data are mean (SD). DACOBS=Davos Assessment of Cognitive Biases Scale.
Table 2: Treatment efficacy for outcome measures in the intervention and control groups
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Significant interaction effects were noted for attention 
for threat and social cognitive problems at the post-
treatment assessment (table 3). No significant treatment 
effects were found for positive and negative beliefs of self 
or others (table 3).
Mediation analysis showed that part of the treatment 
effect on paranoid ideation (measured by the Green et al 
Paranoid Thoughts Scale) at the post-treatment assessment 
was mediated by change in safety behaviour (percentage 
mediated 33·7%) and change in social cognitive problems 
(percentage mediated 19·2%; table 3; appendix). Indivi-
duals who received VR-CBT used less safety behaviour and 
reported fewer social cognition problems than did those in 
the control group, and in turn experienced less paranoid 
ideation. Jumping to conclusions and attention for threat 
did not mediate the effect of treatment on paranoid 
ideation (table 4). The direct effect of the treatment on 
paranoid ideation was no longer significant after inclusion 
of the mediators in the model (p=0·060). The indirect 
effect of safety behaviour was not significantly larger than 
the indirect effect of social cognition problems (bootstrap 
CI of the contrast –3·4 to 7·5). None of the included 
mediators significantly mediated the effect of VR-CBT on 
momentary paranoia as measured with ESM (table 4). The 
total effect (independent of mediators) and direct effect 
(including the mediators) of treatment were both 
significant for momentary paranoia (table 4).
D ussion
To our knowledge, ours is the first randomised controlled 
trial of VR-CBT to treat paranoid ideation and social 
avoidance in patients with psychotic disorders. Although 
the amount of time spent with others did not increase 
after VR-CBT compared with the control, VR-CBT 
resulted in large reductions in momentary paranoia and 
anxiety during social interactions, not only at the 
post-treatment assessment, but also at the 6 month 
follow-up assessment. Significant improvements were 
also noted for ideas of persecution, ideas of social 
reference, and use of safety behaviour. The therapeutic 
effect of VR-CBT for paranoid ideation was mediated by 
improvements in safety behaviours and social cognition, 
but mediation effects were not noted for momentary 
paranoia.
Our findings suggest that VR-CBT does not im mediately 
lead to spending more time with others, but helps patients 
to learn how to drop safety behaviours and to have social 
interactions more positively, with less anxiety and 
paranoia after therapy. In turn, these positive experiences 
seem to lead to fewer paranoid thoughts and fewer ideas 
of social reference in general. This interpretation 
was supported by the results of the mediation analysis, 
which showed that reductions in safety behaviour 
accounted for 34% of the change in paranoid ideation, 
and improvements in social cognition for 19%.
How do these mechanisms contribute to reductions in 
paranoid ideation? Safety behaviours interfere with the 
development of new associations and prevent gathering 
of social information. For example, during the first 
sessions, many participants looked at avatars from the 
neck down only, avoiding eye contact. When such safety 
behaviour is dropped, the patient receives more social 
information. Improvements in social cognition can 
result in more adequate interpretations of that 
information, thereby reducing the chance of incorrect 
paranoid appraisals. Safety behaviour was targeted 
explicitly during sessions, because people practised 
within virtual recreations of situations that they would 
usually avoid. Cognition was actively challenged and 
discussed during virtual reality exposures, although in a 
less structured fashion than safety behaviour, which 
could explain the absences of findings for several 
cognitive biases.
No mediating effects were identified for momentary 
paranoia as measured by ESM. Although this finding 
seems contradictory to the results for paranoid ideation 
on the Green et al Paranoid Thoughts Scale, it could be 
explained by the nature of the scales. The Green et al 
Paranoid Thoughts Scale assesses paranoia with 
32 items, whereas momentary paranoia is composed of 
three items. Thus variation in ESM scores tends to be 
lower, and the ESM scale might be less sensitive to 
changes. Additionally, retrospectively measured paranoid 
ideation could capture different constructs from those 
captured by measurement of momentary state paranoia. 
ESM is ecologically valid, but also seems to be comp-
lementary to retrospective measures rather than a 
measurement of the same constructs.36
Overall, expansion of social activities and improvement 
of social functioning seem to require more time and are 
mainly accomplished in the period after therapy. Patients 
in symptomatic remission do not immediately spend 
more time with others.37 When patients increasingly feel 
more comfortable in social situations and learn that 
other people are less threatening than anticipated, they 
might try and succeed to make and maintain social 
Paranoid ideation* (n=101) Momentary paranoia† (n=95)
Effect p 95% bootstrap CI Effect p 95% bootstrap CI
Total effect 13·72 0·0024 ·· 0·38 0·012 ··
Direct effect 6·83 0·060 ·· 0·28 0·042 ··
Indirect effect safety 
behaviour
4·62 ·· 0·62 to 10·21 0·02 ·· –0·01 to 0·26
Indirect effect 
attention for threat
–0·35 ·· –3·86 to 1·71 0·06 ·· –0·01 to 0·23
Indirect effect social 
cognitive problems
2·63 ·· 0·05 to 8·01 0·05 ·· –0·03 to 0·25
Indirect effect jumping 
to conclusions
–0·01 ·· –1·49 to 1·49 -0·03 –0·17 to 0·01
Mediation analysis was done by the method described by Hayes and Rockwood.34 Baseline and post-treatment values 
were used. Baseline values of outcome and mediator variables were added as covariates to the model. *Measured with 
Green et al Paranoid Thoughts Scale. †Measured with Experience Sampling Method.
Table 4: Results of mediation analysis
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contacts and find hobbies and jobs. At the follow-up 
assessment in our study, a positive effect of VR-CBT was 
noted for stigma and social and occupational functioning. 
Furthermore, resolution of symptoms might not 
auto matically improve social functioning—negative 
symptoms and deficient social skills could get in the way. 
Additional training might be needed.
Our results are in line with a virtual reality pilot study38 
for treatment of ideas of persecution, in which significant 
reductions in delusional conviction and real-world 
distress were noted after one session. Similar to virtual 
reality interventions for social skills and job interview 
training for people with schizophrenia, our intervention 
was generalisable to everyday life.9 Although many virtual 
reality studies have a high frequency of dropouts due to 
cybersickness,39 in our study only one participant 
had cybersickness to the extent that he quit treatment. 
Cybersickness might become less of a problem as a 
result of improvements in technology.
Perception of social threat, as measured by ESM, was 
not significantly affected by VR-CBT. Collip and 
colleagues17 noted that perceived social threat was more 
often reported in the company of less familiar people 
than in the presence of familiar people. However, the 
term social threat could be misleading, because the items 
on the ESM could also express the wish to enjoy company 
versus a preference for being alone. This scale thus needs 
further validation.
A strength of our study is the use of ESM to assess 
treatment effects in the flow of daily life. Another 
strength is the pragmatic effectiveness design of the 
study. The study was done in seven mental health 
centres, and treatment was delivered within standard 
services by regularly employed therapists. Therapists’ 
experience with exposure therapy and CBT varied. Our 
results suggest the effectiveness of VR-CBT in real-world 
conditions in a sample of patients who are representative 
of standard clinical practice.
Our study also had several limitations. First, we did not 
use an active control group, such as CBT with exposure 
in vivo. Thus we cannot rule out a dose-effect of 
therapeutic contacts. Second, the long-term effects of 
VR-CBT remain unknown, because follow-up was 
restricted to 6 months. Third, technological limitations 
restricted conversational interaction possibilities between 
participants and avatars. Therefore VR-CBT could not 
sufficiently address conversational issues. Fourth, a 
potential limitation of VR-CBT is that patients are not 
exposed to unexpected surprises that can occur in life. 
Although this criticism is valid, many patients with 
psychosis become too frightened in real-life situations, 
preventing them from dropping safety behaviours or 
causing them to avoid exposure. To prevent the risk that 
the presence of the therapist becomes a safety signal, as 
therapy progresses the therapist should become less 
prominently present and should guide the patient less. 
Fifth, some eligible patients did not participate because 
they were too frightened to travel to the therapy location. 
Thus our sample might have been biased, because some 
of the most paranoid and avoidant patients could not 
participate. Additionally, little is known about the patients 
who seemed eligible on the basis of screening but did not 
consent to be contacted, or about the people who provided 
consent to be contacted, but did not respond. Further-
more, we could not recruit the aimed number of 
participants within our financial and time limits. The 
study is thus somewhat underpowered. Finally, the 
temporal order of the mediation analysis was based on 
the assumed mechanisms of VR-CBT, but reverse 
causality cannot be ruled out. That said, we agree with 
Hayes and Rockwood34 that mediation analysis, despite 
limitations, provides useful insights into clinical research 
findings. Although no final conclusions can be drawn, 
our findings support the predetermined hypothesis.
In conclusion, in patients with a psychotic disorder, 
our findings support the hypothesis that VR-CBT 
strongly reduces paranoid ideation, momentary anxiety, 
and safety behaviours in real-life social situations. This 
study shows that targeting safety behaviour and social 
cognitive appraisals in psychotherapy with virtual reality 
can effectively reduce paranoid thoughts. Future research 
should compare VR-CBT with standard cognitive 
behavioural therapy in terms of both treatment effects 
and cost-effectiveness.
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